Cardiovascular and Metabolic Sciences Biorepository
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorThe Cleveland Clinic
About this trial
The purpose of the Cardiovascular and Metabolic Sciences Biorepository is to collect and store information and biospecimens (blood, urine, stool, and heart tissue) from patients with and without cardiovascular and metabolic diseases to create a readily available biorepository of samples and related medical health information to expedite future research into the causes and consequences of cardiovascular and metabolic diseases.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Willing and able to sign the informed consent document
Disqualifiers
Chronic anemia (hemoglobin consistently <9 g/L)
Trial population
We will enroll persons with diagnosed cardiovascular or metabolic disease(s), persons with a family history of cardiovascular and/or metabolic disease(s), and persons without known cardiovascular or metabolic disease(s). The targeted number of participants to be enrolled is indefinite.
Trial design
Design model
Cohort
Time perspective
Other
Treatments tested in this trial
Not listed
Trial groups
10,000 Participants
are grouped into 3 trial groupsGroup A: Personal History of Cardiovascular or Metabolic Diseases
Group B: Family History of Cardiovascular or Metabolic Diseases
Group C: Healthy Controls
Trial outcomes
Primary outcomes
1
Number of samples enrolled per year
Establish a biorepository of samples (blood, urine, stool, and heart tissue) and related medical health information to support future investigation into cardiovascular and metabolic diseases.
Time frame
Yearly through study completion (approximately 30 years)Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov